1.03

Questions and Answers

What is the primary distinction between tachyarrhythmias?

They are classified as ventricular or supraventricular. (correct)

They are classified as benign or malignant.

They are either atrial or ventricular.

They are either functional or structural.

From which areas do supraventricular arrhythmias originate?

From the Purkinje fibers.

From the bundle of His.

From the ventricles.

From the atrium or AV node. (correct)

What characterizes Physiologic Sinus Tachycardia (ST)?

Precipitated by exertion or stress with a heart rate greater than 100 bpm. (correct)

Typically seen in patients with COPD.

P-wave is not present in standard leads.

Occurs spontaneously at rest without reason.

Which statement best describes Focal Atrial Tachycardia?

It may be paroxysmal lasting for more than 30 seconds. Signup and view all the answers

What distinguishes Multifocal Atrial Tachycardia from other types of tachycardia?

Shows at least three distinct P-wave morphologies. Signup and view all the answers

In which demographic is Non-physiologic Sinus Tachycardia predominantly seen?

Women in their 3rd to 4th decade of life. Signup and view all the answers

How is Atrial Flutter characterized on an ECG?

Sawtooth flutter waves with high heart rates. Signup and view all the answers

What does the term 'paroxysmal' refer to in Paroxysmal Supraventricular Tachycardia (PSVT)?

It comes and goes. Signup and view all the answers

What is one method through which AVNRT can initiate in patients?

Through a fast or slow pathway in the AV node. Signup and view all the answers

In what scenario can Antidromic AVRT present as a wide QRS tachycardia?

When the impulse travels downward via the accessory pathway. Signup and view all the answers

Which characteristic is true about Orthodromic AVRT?

The impulse travels through the AV node first. Signup and view all the answers

What scoring system is used to assess stroke risk in patients with Atrial Fibrillation?

CHA2DS2-VASc Score Signup and view all the answers

Which type of Atrial Fibrillation is characterized as being consistently present without the possibility of conversion to sinus rhythm?

Permanent Signup and view all the answers

Which comorbidity is NOT commonly associated with an increased risk of Atrial Fibrillation?

Asthma Signup and view all the answers

What therapy is often used for anticoagulation in patients with Atrial Fibrillation?

Warfarin Signup and view all the answers

What is recommended for patients aged 65 years and older during AF screening?

Opportunistic screening by pulse taking or ECG rhythm strip Signup and view all the answers

Which procedure should be performed regularly for patients with pacemakers?

Interrogate for AHRE Signup and view all the answers

What should be clarified to individuals undergoing AF screening?

The significance and treatment implications of detecting AF Signup and view all the answers

Which medical tests are included in the diagnostic work-up for all AF patients?

12-lead ECG and thyroid function tests Signup and view all the answers

What is assessed in selected AF patients through ambulatory ECG monitoring?

Adequacy of rate control and relate symptoms to AF recurrences Signup and view all the answers

Which test is used to help decision-making in AF treatment?

LGE-CMR of the left atrium Signup and view all the answers

Who should coordinate the structured follow-up for AF patients?

A cardiologist or AF specialist Signup and view all the answers

What does a score of 2a on the EHRA symptom scale signify?

Normal daily activity not affected, but patient troubled by symptoms Signup and view all the answers

Which of the following symptoms contributes to the assessment of the EHRA symptom scale?

Palpitations Signup and view all the answers

Which description best defines a score of 4 on the EHRA symptom scale?

Normal daily activity discontinued Signup and view all the answers

What is the purpose of the EHRA symptom scale?

To quantify AF-related symptoms for treatment decisions Signup and view all the answers

What limitation does the EHRA symptom scale have?

It does not consider general quality of life factors Signup and view all the answers

Which is NOT a symptom evaluated by the EHRA symptom scale?

Headache Signup and view all the answers

How are treatment decisions influenced according to the EHRA symptom scale?

Through quantified patient perception of symptoms Signup and view all the answers

In what way is the EHRA symptom scale related to patient outcomes?

Higher scores are connected to adverse outcomes in symptomatic patients Signup and view all the answers

Which of the following is considered a risk factor for Atrial Fibrillation?

Hypertension Signup and view all the answers

What is the target HbA1c level suggested in managing glycaemia for Atrial Fibrillation?

Less than 6.5% Signup and view all the answers

Which of the following conditions is characterized by a Body Mass Index (BMI) of less than 27 kg/m² and is a risk factor for Atrial Fibrillation?

Overweight Signup and view all the answers

Which risk factor for Atrial Fibrillation is associated with cessation of smoking?

Smoking Signup and view all the answers

What does the acronym OSA represent as a risk factor for Atrial Fibrillation?

Obstructive Sleep Apnea Signup and view all the answers

What does the CHADSVASc scoring system assess in relation to Atrial Fibrillation management?

Risk of stroke Signup and view all the answers

What is the primary indication for using the HASBLED score?

To assess bleeding risk factors Signup and view all the answers

What medication is suggested to improve symptoms in patients with Atrial Fibrillation?

B blockers Signup and view all the answers

What does a CHADSVASc score of 3 indicate?

High risk of stroke Signup and view all the answers

Which factor is NOT considered in the HASBLED score assessment?

Heart rate Signup and view all the answers

What are premature ventricular beats also known as?

Premature Ventricular Depolarizations Signup and view all the answers

What characterizes monomorphic ventricular tachycardia?

Single form in appearance Signup and view all the answers

In which patients would you expect to see ventricular tachycardia commonly?

Patients with heart weakness and history of MI Signup and view all the answers

What is the normal heart rate for ventricular tachycardia?

20-40 bpm Signup and view all the answers

What describes Ventricular Flutter?

Characterized by a rapid heart rate where the + and – points are not recognizable Signup and view all the answers

What are some potential clinical manifestations of ventricular arrhythmias?

Palpitations and dizziness Signup and view all the answers

Which condition can occur if Ventricular Tachycardia is not addressed?

Ventricular Fibrillation Signup and view all the answers

Which of the following symptoms is NOT typically associated with ventricular arrhythmias?

Increased appetite Signup and view all the answers

Study Notes

Tachyarrhythmias Overview

Tachyarrhythmias are abnormal rapid heart rhythms, categorized into ventricular and supraventricular types.
These conditions can lead to significant cardiovascular effects and may require medical intervention.

Supraventricular Arrhythmias (SVT)

SVTs originate from the atrium or atrioventricular (AV) node, impacting the upper chambers of the heart.
Typically characterized by a narrow QRS complex on an electrocardiogram (ECG), indicating that the impulse is conducted rapidly through the heart.
Common types of SVT include atrial fibrillation, atrial flutter, and paroxysmal tachycardia.
Symptoms may include palpitations, dizziness, shortness of breath, or chest pain.
Treatment options vary and may include medication, electrical cardioversion, or catheter ablation, depending on severity and underlying causes.

Supraventricular Arrhythmias (SVT)

Physiologic Sinus Tachycardia (ST)
- Results from normal sinus mechanism triggered by factors like exertion, stress, or concurrent illnesses.
- Characterized by a heart rate greater than 100 bpm.
- P-waves are upright in leads II, III, and AVF, but negative in AVR.
Non-physiologic Sinus Tachycardia
- Sinus rate increases spontaneously at rest or disproportionately to physiological stress/exertion.
- Primarily affects women in their 30s to 40s.
Focal Atrial Tachycardia
- Defined by a regular tachycardia with a distinct P wave present.
- Can be sustained, non-sustained (lasting for more than 30 seconds), paroxysmal, or incessant.
Multifocal Atrial Tachycardia
- Characterized by a rhythm showing at least three different P-wave morphologies.
- Typically presents with heart rates ranging from 100 to 150 bpm.
- Commonly seen in patients with chronic obstructive pulmonary disease (COPD) and acute illnesses.
Atrial Flutter
- Organized reentry mechanism leads to orchestrated atrial activity.
- Notable for sawtooth-shaped flutter waves observed at heart rates typically exceeding 200 bpm.

Paroxysmal Supraventricular Tachycardia (PSVT)

PSVT is characterized by intermittent episodes of tachycardia, meaning it comes and goes.
It typically presents as narrow QRS complex tachycardia.

Mechanisms of PSVT

Two primary mechanisms involved:
- AVNRT (Atrioventricular Nodal Re-entry Tachycardia)
- AVRT (Atrioventricular Re-entry Tachycardia)

AVNRT (Atrioventricular Nodal Re-entry Tachycardia)

Involves a fast and a slow pathway within the AV node.
During normal sinus rhythm, impulse travels through the fast pathway to ventricles, initiating the cycle again.

AVRT (Atrioventricular Re-entry Tachycardia)

Occurs due to an accessory conduction pathway from incomplete closure of the annulus, associated with tricuspid or mitral valve.

Orthodromic AVRT

Impulse travels from the atrium to the AV node, then down to the ventricles.
Returns to the atria via the accessory pathway, resulting in a narrow QRS complex tachycardia.

Antidromic AVRT

Impulse travels down to the ventricles first through the accessory pathway.
This can lead to wide QRS complex tachycardia, a noted exception in PSVTs, which usually manifest as narrow QRS complexes.
Not all PSVT cases feature narrow QRS; some can present as wide complex tachycardia.

Atrial Fibrillation

Atrial fibrillation (AF) is the most common and significant form of supraventricular tachycardia (SVT), characterized by disorganized, rapid, and irregular atrial activation.
AF leads to the loss of effective atrial contraction and results in an irregular ventricular rate.

Management of Atrial Fibrillation

Stroke Risk Assessment: CHA2DS2-VASc Score is crucial for evaluating stroke risk; a higher score indicates a greater need for anticoagulation therapy.
- Anticoagulation options include Warfarin and direct oral anticoagulants such as Rivaroxaban and Apixaban.
Symptom Severity Control: Symptoms can range from mild to severely debilitating. Assessing symptom severity is vital for understanding its impact on the patient's quality of life.
AF Burden Control: The classification of AF can be categorized into:
- Paroxysmal: Episodes that terminate spontaneously.
- Persistent: Episodes that last longer than seven days but require intervention.
- Long-standing Persistent: AF lasting over 12 months.
- Permanent: AF that is accepted and not pursued for restoration of sinus rhythm.
Substrate Severity Control: Addressing underlying comorbidities is essential to manage AF:
- Common comorbidities include hypertension (HTN), diabetes, and obesity, which can predispose patients to AF.
- Efforts should focus on either restoring sinus rhythm or controlling the rate of AF while managing these comorbid conditions.

Recommendations for Screening to Detect Atrial Fibrillation (AF)

Opportunistic screening for AF through pulse checks or ECG rhythm strips is recommended for individuals aged 65 and older.
Regular interrogation of pacemakers and implantable cardioverter defibrillators is advised to identify atrial high rate episodes (AHRE).
When screening for AF, it's crucial that:
- Screened individuals understand the significance and treatment implications of AF detection.
- A structured referral system exists for confirmed positive cases to ensure physician-led evaluation and management.
- A definitive diagnosis of AF is made after a physician reviews a single-lead ECG recording of at least 30 seconds or a 12-lead ECG.
Systematic ECG screening is suggested for those aged 75 and older, or individuals at high risk for stroke.

Diagnostic Work-Up for All AF Patients

Comprehensive medical history is essential, including:
- Symptoms related to AF.
- Various patterns of AF.
- Concurrent medical conditions.
- Calculation of the CHA2DS2-VASc score.
A 12-lead ECG is crucial in diagnosis.
Assess thyroid and kidney functions, electrolytes, and perform a full blood count.
Transthoracic echocardiography is part of the standard procedure.

Additional Diagnostics for Selected AF Patients

Ambulatory ECG monitoring aids in evaluating rate control and correlating symptoms with AF episodes.
Transoesophageal echocardiography is valuable for assessing:
- Valvular heart disease.
- Presence of thrombus in the left atrial appendage (LAA).
Biomarker tests like high sensitivity cardiac troponin T (cTnT-hs), CRP, and BNP/NT-ProBNP can be informative.
Cognitive function assessment may be part of the evaluation.
Coronary CTA or ischemia imaging is indicated for patients suspected of having coronary artery disease (CAD).
Brain CT and MRI are recommended for those with suspected strokes.
Late Gadolinium Contrast-Enhanced Cardiac MRI (LGE-CMR) can guide treatment decisions regarding AF.

Structured Follow-Up

Continuous optimal management is essential for AF patients.
Coordination of follow-up is led by a cardiologist or AF specialist, in collaboration with trained nursing staff and primary care physicians.

EHRA Symptom Scale

The EHRA Symptom Scale categorizes atrial fibrillation (AF) symptoms into five scores based on severity and impact on daily activities.
Scores range from 1 (no symptoms) to 4 (disabling symptoms), with detailed descriptions for each severity level.
Symptoms assessed include palpitations, fatigue, dizziness, dyspnoea, chest pain, and anxiety related to AF.
The scale helps to evaluate how symptoms influence a patient's normal daily activities, focusing particularly on those with moderate to severe symptoms (scores 3-4).

Treatment and Quality of Life

Quality of life (QoL) and symptom questionnaires must be sensitive to changes in AF burden to measure treatment effectiveness accurately.
The EHRA Symptom Scale acts as a physician-assessed tool, guiding treatment decisions based on the quantification of AF-related symptoms.
There is a noted relationship between higher symptom scores (3-4) and adverse patient outcomes compared to lower scores (1-2).

Limitations and Patient Perspectives

The scale does not incorporate other symptom dimensions, including treatment concerns, anxiety, or medication side effects, which are acknowledged by general QoL scales.
Discrepancies often exist between patient-reported outcomes and physician assessments; therefore, capturing patient perceptions of symptoms is essential for informed treatment decisions.
Further research is needed to identify optimal tools for measuring patient-reported AF symptoms effectively.

Risk Factors for Atrial Fibrillation (AF)

Glycaemia is identified as a significant risk factor for Atrial Fibrillation.
A target reduction of more than 10% in HbA1c levels is associated with decreased AF risk.
Maintaining optimal HbA1c levels is crucial for managing glycaemia and potentially reducing the incidence of AF.

Anticoagulation for Atrial Fibrillation (AF) Management

CHADSVASc score of 3 indicates a moderate to high risk for stroke, warranting careful anticoagulation therapy.
HASBLED score of 1 suggests a low risk of bleeding; the focus is on identifying modifiable risk factors, not the presence of contraindications.
Aim to minimize bleeding risks while using oral anticoagulants by addressing factors such as hypertension, liver function, and alcohol consumption.

Symptom Management in AF

Emphasizing patient-centered care, symptom relief should align with patient preferences.
Use of beta-blockers is recommended to achieve the target control rate (CR) in symptom management.

Ventricular Arrhythmias Overview

Account for approximately 80% of sudden cardiac death cases.
Typically present as wide QRS complex tachycardia.
Can originate from either the right or left ventricle.

Premature Ventricular Beats (PVBs)

Also known as Premature Ventricular Depolarizations (PVDs).
Characterized by "skip beats" occurring individually or in patterns such as bigeminy, trigeminy, or quadrigeminy.

Ventricular Tachycardia

Normal heart rate ranges from 20 to 40 beats per minute.
Common in patients with weakened hearts, cardiomyopathy, or a history of myocardial infarction (MI).
Patients often experience palpitations and may have a need for monitoring or treatment.

Types of Ventricular Tachycardia

Monomorphic Ventricular Tachycardia: Exhibits a single, consistent form on the ECG.
Polymorphic Ventricular Tachycardia: Displays multiple forms; variations in morphology can be observed (sharp downward and upward deflections) in the same lead.

Ventricular Flutter

Characterized by extremely rapid heart rates, where distinct positive and negative points on the ECG are not recognizable.
It represents a type of tachycardia that can lead to serious complications if not managed properly.

Ventricular Fibrillation

Described as a chaotic, ineffective contraction or quivering of the heart muscle, leading to a lack of blood flow.
Often occurs as a progression from untreated ventricular tachycardia (V-Tach).
Can ultimately result in cardiac arrest or "flat lining," a critical emergency situation requiring immediate intervention.

Clinical Manifestations

Common symptoms include:
- Palpitations, which may feel like a racing or irregular heartbeat.
- Dizziness, indicating potential inadequate blood flow to the brain.
- Exercise intolerance, where individuals may struggle with physical activity due to insufficient cardiac output.
- Lightheadedness, a feeling of faintness often linked to changes in blood pressure.
- Syncope, or sudden loss of consciousness, signaling severe cardiovascular instability.
- Sudden death, which can occur if arrhythmias like ventricular fibrillation are not rapidly addressed.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Description

Test your knowledge on tachyarrhythmias, focusing on the classification between ventricular and supraventricular arrhythmias. Explore the characteristics and origins of supraventricular arrhythmias, including conduction through the atrium and AV node.